Published in Cloning Stem Cells on March 01, 2008
Derivation and propagation of human embryonic stem cell lines from frozen embryos in an animal product-free environment. Nat Protoc (2012) 3.30
Mesenchymal stem cells and their use as cell replacement therapy and disease modelling tool. J Cell Mol Med (2008) 1.27
Human embryonic stem cell cultivation: historical perspective and evolution of xeno-free culture systems. Reprod Biol Endocrinol (2015) 0.89
Efficient derivation and genetic modifications of human pluripotent stem cells on engineered human feeder cell lines. Stem Cells Dev (2012) 0.88
Morphological analysis of human induced pluripotent stem cells during induced differentiation and reverse programming. Biores Open Access (2014) 0.79
Effects of Feeder Cells on Dopaminergic Differentiation of Human Embryonic Stem Cells. Front Cell Neurosci (2016) 0.75
Effect of CPAP on blood pressure in patients with obstructive sleep apnea and resistant hypertension: the HIPARCO randomized clinical trial. JAMA (2013) 4.18
Cytokines and BMP-4 promote hematopoietic differentiation of human embryonic stem cells. Blood (2003) 3.98
IGF and FGF cooperatively establish the regulatory stem cell niche of pluripotent human cells in vitro. Nature (2007) 3.74
Drug-induced liver injury: an analysis of 461 incidences submitted to the Spanish registry over a 10-year period. Gastroenterology (2005) 3.52
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive properties applicable for the control of the graft-versus-host disease. Stem Cells (2006) 3.02
Endothelial and hematopoietic cell fate of human embryonic stem cells originates from primitive endothelium with hemangioblastic properties. Immunity (2004) 2.89
Gender and COPD in patients attending a pulmonary clinic. Chest (2005) 2.59
Generation of hematopoietic repopulating cells from human embryonic stem cells independent of ectopic HOXB4 expression. J Exp Med (2005) 2.42
Antilymphocyte Globulin for Prevention of Chronic Graft-versus-Host Disease. N Engl J Med (2016) 2.36
Clonal isolation of hESCs reveals heterogeneity within the pluripotent stem cell compartment. Nat Methods (2006) 2.31
Embryonic stem cell-specific miR302-367 cluster: human gene structure and functional characterization of its core promoter. Mol Cell Biol (2008) 1.74
The miR-302-367 cluster as a potential stemness regulator in ESCs. Cell Cycle (2009) 1.68
Intra-bone marrow transplantation of human CD34(+) cells into NOD/LtSz-scid IL-2rgamma(null) mice permits multilineage engraftment without previous irradiation. Cytotherapy (2010) 1.64
Human ESCs predisposition to karyotypic instability: Is a matter of culture adaptation or differential vulnerability among hESC lines due to inherent properties? Mol Cancer (2008) 1.55
FLT3 activation cooperates with MLL-AF4 fusion protein to abrogate the hematopoietic specification of human ESCs. Blood (2013) 1.55
A promoter DNA demethylation landscape of human hematopoietic differentiation. Nucleic Acids Res (2011) 1.49
Human embryonic stem cells maintained in the absence of mouse embryonic fibroblasts or conditioned media are capable of hematopoietic development. Blood (2005) 1.49
Epigenetic silencing of engineered L1 retrotransposition events in human embryonic carcinoma cells. Nature (2010) 1.47
Dopamine mobilizes mesenchymal progenitor cells through D2-class receptors and their PI3K/AKT pathway. Stem Cells (2014) 1.41
Human induced pluripotent stem cells develop teratoma more efficiently and faster than human embryonic stem cells regardless the site of injection. Stem Cells (2010) 1.36
Bone marrow mesenchymal stem cells from infants with MLL-AF4+ acute leukemia harbor and express the MLL-AF4 fusion gene. J Exp Med (2009) 1.31
Enrichment of human ESC-derived multipotent mesenchymal stem cells with immunosuppressive and anti-inflammatory properties capable to protect against experimental inflammatory bowel disease. Stem Cells (2011) 1.27
The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302 in human embryonic stem cells. FASEB J (2011) 1.27
OP9 stroma augments survival of hematopoietic precursors and progenitors during hematopoietic differentiation from human embryonic stem cells. Stem Cells (2008) 1.24
Etoposide induces MLL rearrangements and other chromosomal abnormalities in human embryonic stem cells. Carcinogenesis (2009) 1.23
Comparable survival between HIV+ and HIV- non-Hodgkin and Hodgkin lymphoma patients undergoing autologous peripheral blood stem cell transplantation. Blood (2009) 1.23
Localized mucosal leishmaniasis due to Leishmania (Leishmania) infantum: clinical and microbiologic findings in 31 patients. Medicine (Baltimore) (2003) 1.20
Feeder-free maintenance of hESCs in mesenchymal stem cell-conditioned media: distinct requirements for TGF-beta and IGF-II. Cell Res (2009) 1.14
Deficiency in p53 but not retinoblastoma induces the transformation of mesenchymal stem cells in vitro and initiates leiomyosarcoma in vivo. Cancer Res (2010) 1.13
Cancer genes hypermethylated in human embryonic stem cells. PLoS One (2008) 1.12
Gender associated differences in determinants of quality of life in patients with COPD: a case series study. Health Qual Life Outcomes (2006) 1.12
Hematopoietic development from human embryonic stem cell lines. Exp Hematol (2005) 1.11
SCL/TAL1 regulates hematopoietic specification from human embryonic stem cells. Mol Ther (2012) 1.09
HLA class II genotype influences the type of liver injury in drug-induced idiosyncratic liver disease. Hepatology (2004) 1.09
Nodal/Activin signaling predicts human pluripotent stem cell lines prone to differentiate toward the hematopoietic lineage. Mol Ther (2010) 1.09
Modeling sarcomagenesis using multipotent mesenchymal stem cells. Cell Res (2011) 1.09
Loss of p53 induces tumorigenesis in p21-deficient mesenchymal stem cells. Neoplasia (2009) 1.09
Residual expression of the reprogramming factors prevents differentiation of iPSC generated from human fibroblasts and cord blood CD34+ progenitors. PLoS One (2012) 1.08
FUS-CHOP fusion protein expression coupled to p53 deficiency induces liposarcoma in mouse but not in human adipose-derived mesenchymal stem/stromal cells. Stem Cells (2011) 1.07
Granada virus: a natural phlebovirus reassortant of the sandfly fever Naples serocomplex with low seroprevalence in humans. Am J Trop Med Hyg (2010) 1.07
Variable number of tandem repeats of TNF receptor type 2 promoter as genetic biomarker of susceptibility to develop invasive pulmonary aspergillosis. Hum Immunol (2006) 1.06
Interleukin-10 promoter polymorphism as risk factor to develop invasive pulmonary aspergillosis. Immunol Lett (2007) 1.06
iPSCs from cancer cells: challenges and opportunities. Trends Mol Med (2012) 1.04
Dedifferentiated adult articular chondrocytes: a population of human multipotent primitive cells. Exp Cell Res (2004) 1.01
Maintenance of human embryonic stem cells in mesenchymal stem cell-conditioned media augments hematopoietic specification. Stem Cells Dev (2011) 1.00
Dectin-1 and DC-SIGN polymorphisms associated with invasive pulmonary Aspergillosis infection. PLoS One (2012) 1.00
Large-scale transcriptional profiling and functional assays reveal important roles for Rho-GTPase signalling and SCL during haematopoietic differentiation of human embryonic stem cells. Hum Mol Genet (2011) 0.99
The ROCK inhibitor Y-27632 negatively affects the expansion/survival of both fresh and cryopreserved cord blood-derived CD34+ hematopoietic progenitor cells: Y-27632 negatively affects the expansion/survival of CD34+HSPCs. Stem Cell Rev (2010) 0.98
Conventional and molecular cytogenetic diagnostic methods in stem cell research: a concise review. Cell Biol Int (2007) 0.98
The adaptation of human embryonic stem cells to different feeder-free culture conditions is accompanied by a mitochondrial response. Stem Cells Dev (2011) 0.97
Early-phase adaptations to intrahospital training in strength and functional mobility of children with leukemia. J Strength Cond Res (2007) 0.97
A human ESC model for MLL-AF4 leukemic fusion gene reveals an impaired early hematopoietic-endothelial specification. Cell Res (2012) 0.95
iPSC lines that do not silence the expression of the ectopic reprogramming factors may display enhanced propensity to genomic instability. Cell Res (2010) 0.93
Physical activity during treatment in children with leukemia: a pilot study. Appl Physiol Nutr Metab (2006) 0.93
In vitro culture of Borrelia garinii results in loss of flagella and decreased invasiveness. Infect Immun (2002) 0.92
Expression of FUS-CHOP fusion protein in immortalized/transformed human mesenchymal stem cells drives mixoid liposarcoma formation. Stem Cells (2013) 0.91
Concise review: Generation of neurons from somatic cells of healthy individuals and neurological patients through induced pluripotency or direct conversion. Stem Cells (2014) 0.91
Maintenance of human embryonic stem cells in media conditioned by human mesenchymal stem cells obviates the requirement of exogenous basic fibroblast growth factor supplementation. Tissue Eng Part C Methods (2012) 0.90
Cord blood-derived CD34+ hematopoietic cells with low mitochondrial mass are enriched in hematopoietic repopulating stem cell function. Haematologica (2013) 0.90
Cell-cell adhesion in the prelaminar region of the optic nerve head: a possible target for ionic stress. Ophthalmic Res (2009) 0.89
Endoplasmic reticulum stress signals in defined human embryonic stem cell lines and culture conditions. Stem Cell Rev (2010) 0.87
Mapping the surface astrocytes of the optic disc: a fluid-conducting role of the astrocytic covering of the central vessels. Clin Experiment Ophthalmol (2010) 0.87
Fenestrations and preferential flow routes in the prelaminar optic nerve through wet scanning electron microscope and perfusion of tracers. Clin Experiment Ophthalmol (2010) 0.86
Bone environment is essential for osteosarcoma development from transformed mesenchymal stem cells. Stem Cells (2014) 0.84
Intra-bone marrow transplantation facilitates pauci-clonal human hematopoietic repopulation of NOD/SCID/beta2m(-/-) mice. Exp Hematol (2005) 0.84
Bone microenvironment signals in osteosarcoma development. Cell Mol Life Sci (2015) 0.83
Nucleocytoplasmic shuttling of STK16 (PKL12), a Golgi-resident serine/threonine kinase involved in VEGF expression regulation. Exp Cell Res (2005) 0.83
Derivation and characterization of hematopoietic cells from human embryonic stem cells. Methods Mol Biol (2006) 0.83
Molecular profiling of candidate human hematopoietic stem cells derived from human embryonic stem cells. Exp Hematol (2008) 0.83
Risk of multiple myeloma is associated with polymorphisms within telomerase genes and telomere length. Int J Cancer (2014) 0.82
Specific marking of hESCs-derived hematopoietic lineage by WAS-promoter driven lentiviral vectors. PLoS One (2012) 0.82
Mesenchymal niches of bone marrow in cancer. Clin Transl Oncol (2011) 0.81
The globoseries glycosphingolipid SSEA-4 is a marker of bone marrow-derived clonal multipotent stromal cells in vitro and in vivo. Stem Cells Dev (2013) 0.81
Multipotent mesenchymal stromal cells: clinical applications and cancer modeling. Adv Exp Med Biol (2012) 0.81
Efficient and nontoxic adenoviral purging method for autologous transplantation in breast cancer patients. Cancer Res (2002) 0.80
Purification and long-term expansion of multipotent endothelial-like cells with potential cardiovascular regeneration. Stem Cells Dev (2011) 0.80
Concise review: induced pluripotency by defined factors: prey of oxidative stress. Stem Cells (2015) 0.80
In vivo ectopic implantation model to assess human mesenchymal progenitor cell potential. Stem Cell Rev (2013) 0.79
Oseltamivir-resistant pandemic influenza a (H1N1) 2009 viruses in Spain. J Clin Virol (2011) 0.79
Impact of polymorphic variation at 7p15.3, 3p22.1 and 2p23.3 loci on risk of multiple myeloma. Br J Haematol (2012) 0.78
Intrahepatic transplantation of cord blood CD34+ cells into newborn NOD/SCID-IL2Rγ(null) mice allows efficient multi-organ and multi-lineage hematopoietic engraftment without accessory cells. Clin Immunol (2012) 0.78
Identification of a candidate proteomic signature to discriminate multipotent and non-multipotent stromal cells. PLoS One (2012) 0.78
Bone marrow stromal cell-derived Wnt signals as a potential underlying mechanism for cyclin D1 deregulation in multiple myeloma lacking t(11;14)(q13;q32). Blood Cells Mol Dis (2007) 0.78
Comprehensive investigation of genetic variation in the 8q24 region and multiple myeloma risk in the IMMEnSE consortium. Br J Haematol (2012) 0.78
Oncolytic virotherapy for neuroblastoma. Discov Med (2010) 0.78
Absence of clinically relevant effect of caspofungin on cyclosporin pharmacokinetics. Swiss Med Wkly (2005) 0.77
[Infections due to Toscana virus, West Nile virus, and other arboviruses of interest in Europe]. Enferm Infecc Microbiol Clin (2005) 0.77
Genetics and molecular epidemiology of multiple myeloma: the rationale for the IMMEnSE consortium (review). Int J Oncol (2011) 0.77
Spanish stem cell bank interviews examine the interest of couples in donating surplus human IVF embryos for stem cell research. Cell Stem Cell (2007) 0.77
Calcium pump phosphoenzyme from young and old human red cells. Cell Biol Int (2002) 0.77
Intravascular ultrasound measurement of the aortic lumen. Rev Esp Cardiol (2010) 0.77
Genetic variants and multiple myeloma risk: IMMEnSE validation of the best reported associations--an extensive replication of the associations from the candidate gene era. Cancer Epidemiol Biomarkers Prev (2014) 0.77
Negative feedback self-regulation contributes to robust and high-fidelity transmembrane signal transduction. J R Soc Interface (2013) 0.77
[Serological markers in immigrant and Spanish pregnant women in Granada]. Enferm Infecc Microbiol Clin (2010) 0.77
In vivo site-specific recombination using the beta-rec/six system. Biotechniques (2008) 0.76